Clinical Trials Browser

Phase 1/2 × Loratadine × Clear all

NCT06265077 2024-12-13

Novel Preventive Approach Against Filgrastim-Induced Bone Pain in Cancer Patients

Phase 1/2 Completed

Breast Neoplasms